Treatment of alkylating resistant multiple myeloma with vincristine, BCNU, doxorubicin and prednisone (VBAP)

This publication has 13 references indexed in Scilit:

• High-dose cytosine arabinoside in multiple myeloma
  European Journal of Cancer and Clinical Oncology, 1984
• Cross-resistance to alkylating agents in multiple myeloma
  Cancer, 1983
• Progress report on vindesine treatment of melphalan-resistant multiple myeloma
  European Journal of Cancer and Clinical Oncology, 1983
• Vindesine therapy in melphalan-resistant multiple myeloma
  Published by Elsevier ,1981
• Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962), cyclophosphamide plus prednisone (ABC-P) in melphalan-resistant multiple myeloma
  Cancer, 1978
• Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol
  The American Journal of Medicine, 1977
• Combination therapy for multiple myeloma
  Cancer, 1977
• DOXORUBICIN/B.C.N.U. CHEMOTHERAPY FOR MULTIPLE MYELOMA IN RELAPSE
  The Lancet, 1976
• 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data
  Published by JSTOR ,1973
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958